Okay, let's tackle this question about iron therapy and anaphylaxis. The question is asking which iron therapy has the highest risk of anaphylaxis. First, I need to recall the different types of iron supplements available. The main ones are oral iron like ferrous sulfate, and parenteral options like iron dextran, iron sucrose, ferric carboxymaltose, etc.

Anaphylaxis is a severe allergic reaction, so the question is likely pointing towards a parenteral iron preparation that's known for causing such reactions. I remember that iron dextran has been associated with anaphylaxis, especially the non-covalently bound (first-generation) formulations. There was a case where a patient had a severe allergic reaction after receiving iron dextran, which led to its more cautious use now.

Wait, but other parenteral iron products—like iron sucrose or ferric carboxymaltose—have a lower risk? Let me check that. Iron dextran was known for causing anaphylaxis, particularly the older versions. The newer formulations, like iron isomaltoside or ferric carboxymaltose, have better safety profiles. So the correct answer should be the older iron dextran, probably option C or D here. But the options aren't listed in the question. However, the correct answer is likely iron dextran. So the explanation would focus on that.

Now, for the core concept: Parenteral iron therapy, especially iron dextran, is associated with anaphylaxis due to immune response against dextran. The mechanism involves IgE-mediated reactions.

Why the correct answer is right: Iron dextran, particularly the non-covalent type, has high anaphylaxis risk because the dextran portion acts as an allergen. It's a known cause of severe allergic reactions.

Incorrect options: Oral iron (like ferrous sulfate) doesn't cause anaphylaxis. Others like iron sucrose or ferric carboxymaltose have lower risk. So each wrong option is incorrect because they aren't linked to high anaphylaxis rates.

Clinical pearl: Always test for allergies before administering iron dextran and consider alternatives if any history of allergies. Remember that anaphylaxis is rare with newer parenteral iron products.

Putting it all together in the required sections, making sure to mention iron dextran as the correct answer, and the other options as incorrect due to lower risk.

**Core Concept** Parenteral iron therapy can trigger anaphylaxis due to immune reactivity against the iron complex carrier. Iron dextran, especially non-covalently bound formulations, has the highest anaphylaxis risk among parenteral iron products.

**Why the Correct Answer is Right** Iron dextran (non-covalent) is associated with the highest anaphylaxis risk because the dextran polymer acts as a hapten, inducing IgE-mediated hypersensitivity reactions. This differs from newer covalently bound dextran or carbohydrate-based iron (e.g., iron sucrose, ferric carboxymaltose), which have lower allergenic potential. Pre-treatment skin testing is mandatory for iron dextran due to this risk.

**Why Each Wrong Option is Incorrect**
**Option A:** Oral iron (e.g., ferrous sulfate) causes gastrointestinal side effects but not

✓ Correct Answer: B. Iron dextran